EORTC-QLQ-HN43 feasibility study
Not Applicable
- Conditions
- head and neck cancer
- Registration Number
- JPRN-UMIN000042936
- Lead Sponsor
- Kobe University
- Brief Summary
Results:40 patients were enrolled between July 2021 and October 2021 at two hospitals in Japan. The completion rate at t1 was 97.5% (95%CI: 86.8-99.9). The completion rate at t2 was 87.5% (95%CI: 73.2-95.8). Missing values were more often observed in the Sexuality (items 60 and 61) and Social eating (items 37 and 53) scales of the HN43. Conclusions:Online QOL assessment via CHES during the outpatient chemotherapy was feasible in Japanese patients with HNC.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
Not provided
Exclusion Criteria
1) patient whom physician regard as inappropriate for joining this study 2) unable to QOL questionnaire
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate for the questionnaires in T1.
- Secondary Outcome Measures
Name Time Method Response rate for the questionnaires in T2, the number of rasopnded questions, the number of missing data, reason for the missing data.